Trademarkia Logo

United Kingdom

£
Trademark Search
GENEQURE

View On IPO.GOV.UK

Dead

on 18 Sept 2013

Last Applicant/ Owned by

uniQure IP B.V.

Paasheuvelweg 25

Amsterdam, , 1105 BP

Serial Number

UK00912150091 filed on 18th Sept 2013

Registration Number

UK00912150091 registered on
12th Feb 2014

Correspondent Information

Arnold & Siedsma

16 Upper Woburn Place

London,

WC1H 0AF

GENEQURE

viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vect Read More

Classification Information

Class [1]
Chemical Products

Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors for non-medical research purposes.

Class [5]
Pharmaceutical Products

Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy.

Class [42]
Computer & Software Services & Scientific Services

Research, product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science, chemistry and biochemistry.

Class [44]
Medical, Beauty & Agricultural Services

Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders.

Mark Details

Serial Number

UK00912150091

Mark Type

Word

Kind of mark

Individual